{"id":880,"date":"2020-06-22T12:48:01","date_gmt":"2020-06-22T02:48:01","guid":{"rendered":"https:\/\/test.onephenix.com\/blog\/?p=880"},"modified":"2020-06-22T12:48:01","modified_gmt":"2020-06-22T02:48:01","slug":"scopos-health-powerplays-clinical-trials-are-back","status":"publish","type":"post","link":"https:\/\/test.onephenix.com\/blog\/scopos-health-powerplays-clinical-trials-are-back\/","title":{"rendered":"Scopo\u2019s health powerplays: Clinical trials are back"},"content":{"rendered":"\n
\"\"
Full length portrait of three doctors wearing masks standing by desk in medical clinic, copy space<\/figcaption><\/figure>\n\n\n\n

Cough monitor Resapp (ASX:RAP)<\/strong><\/a> has done a deal with telehealth company Phenix Health, following a similar deal by Respiri (ASX:RSH)<\/strong> <\/a>in April.<\/p>\n\n\n\n

The software licensing agreement for its ResAppDX-EU cough diagnostic test was first announced in March with a price of $5-10 per test. CEO Tony Keating is expecting first commercial revenues in the coming months through the agreements with Phenix Health and Coviu.<\/p>\n\n\n\n

For the full article please visit: https:\/\/stockhead.com.au\/experts\/scopos-health-powerplays-clinical-trials-are-back\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Cough monitor Resapp (ASX:RAP) has done a deal with telehealth company Phenix Health, following a similar deal by Respiri (ASX:RSH) in April. The software licensing agreement for its ResAppDX-EU cough diagnostic test was first announced in March with a price of $5-10 per test. CEO Tony Keating is expecting first commercial revenues in the coming months through the agreements…<\/p>\n","protected":false},"author":5,"featured_media":1879,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32],"tags":[98,106],"class_list":["post-880","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release","tag-phenixhealth","tag-resapp"],"yoast_head":"\nScopo\u2019s health powerplays: Clinical trials are back - Phenix Health<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/test.onephenix.com\/blog\/scopos-health-powerplays-clinical-trials-are-back\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Scopo\u2019s health powerplays: Clinical trials are back - Phenix Health\" \/>\n<meta property=\"og:description\" content=\"Cough monitor Resapp (ASX:RAP) has done a deal with telehealth company Phenix Health, following a similar deal by Respiri (ASX:RSH) in April. The software licensing agreement for its ResAppDX-EU cough diagnostic test was first announced in March with a price of $5-10 per test. CEO Tony Keating is expecting first commercial revenues in the coming months through the agreements...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/test.onephenix.com\/blog\/scopos-health-powerplays-clinical-trials-are-back\/\" \/>\n<meta property=\"og:site_name\" content=\"Phenix Health\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-22T02:48:01+00:00\" \/>\n<meta name=\"author\" content=\"Gillian Alexis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gillian Alexis\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/test.onephenix.com\/blog\/scopos-health-powerplays-clinical-trials-are-back\/\",\"url\":\"https:\/\/test.onephenix.com\/blog\/scopos-health-powerplays-clinical-trials-are-back\/\",\"name\":\"Scopo\u2019s health powerplays: Clinical trials are back - Phenix Health\",\"isPartOf\":{\"@id\":\"https:\/\/test.onephenix.com\/blog\/#website\"},\"datePublished\":\"2020-06-22T02:48:01+00:00\",\"dateModified\":\"2020-06-22T02:48:01+00:00\",\"author\":{\"@id\":\"https:\/\/test.onephenix.com\/blog\/#\/schema\/person\/200244242cc0ef8d220cb8b7c2aee868\"},\"breadcrumb\":{\"@id\":\"https:\/\/test.onephenix.com\/blog\/scopos-health-powerplays-clinical-trials-are-back\/#breadcrumb\"},\"inLanguage\":\"en-AU\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/test.onephenix.com\/blog\/scopos-health-powerplays-clinical-trials-are-back\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/test.onephenix.com\/blog\/scopos-health-powerplays-clinical-trials-are-back\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/test.onephenix.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Scopo\u2019s health powerplays: Clinical trials are back\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/test.onephenix.com\/blog\/#website\",\"url\":\"https:\/\/test.onephenix.com\/blog\/\",\"name\":\"Phenix Health\",\"description\":\"Online Doctor Australia | Telehealth Doctor | Phenix Health\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/test.onephenix.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-AU\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/test.onephenix.com\/blog\/#\/schema\/person\/200244242cc0ef8d220cb8b7c2aee868\",\"name\":\"Gillian Alexis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\/\/test.onephenix.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9ff8e52854b99dc898785ecf20f891c5e051e0f98d52a5228ff8d3ce2a7fe39b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9ff8e52854b99dc898785ecf20f891c5e051e0f98d52a5228ff8d3ce2a7fe39b?s=96&d=mm&r=g\",\"caption\":\"Gillian Alexis\"},\"url\":\"https:\/\/test.onephenix.com\/blog\/author\/q7ewsfmf4x\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Scopo\u2019s health powerplays: Clinical trials are back - Phenix Health","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/test.onephenix.com\/blog\/scopos-health-powerplays-clinical-trials-are-back\/","og_locale":"en_US","og_type":"article","og_title":"Scopo\u2019s health powerplays: Clinical trials are back - Phenix Health","og_description":"Cough monitor Resapp (ASX:RAP) has done a deal with telehealth company Phenix Health, following a similar deal by Respiri (ASX:RSH) in April. The software licensing agreement for its ResAppDX-EU cough diagnostic test was first announced in March with a price of $5-10 per test. CEO Tony Keating is expecting first commercial revenues in the coming months through the agreements...","og_url":"https:\/\/test.onephenix.com\/blog\/scopos-health-powerplays-clinical-trials-are-back\/","og_site_name":"Phenix Health","article_published_time":"2020-06-22T02:48:01+00:00","author":"Gillian Alexis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Gillian Alexis"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/test.onephenix.com\/blog\/scopos-health-powerplays-clinical-trials-are-back\/","url":"https:\/\/test.onephenix.com\/blog\/scopos-health-powerplays-clinical-trials-are-back\/","name":"Scopo\u2019s health powerplays: Clinical trials are back - Phenix Health","isPartOf":{"@id":"https:\/\/test.onephenix.com\/blog\/#website"},"datePublished":"2020-06-22T02:48:01+00:00","dateModified":"2020-06-22T02:48:01+00:00","author":{"@id":"https:\/\/test.onephenix.com\/blog\/#\/schema\/person\/200244242cc0ef8d220cb8b7c2aee868"},"breadcrumb":{"@id":"https:\/\/test.onephenix.com\/blog\/scopos-health-powerplays-clinical-trials-are-back\/#breadcrumb"},"inLanguage":"en-AU","potentialAction":[{"@type":"ReadAction","target":["https:\/\/test.onephenix.com\/blog\/scopos-health-powerplays-clinical-trials-are-back\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/test.onephenix.com\/blog\/scopos-health-powerplays-clinical-trials-are-back\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/test.onephenix.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Scopo\u2019s health powerplays: Clinical trials are back"}]},{"@type":"WebSite","@id":"https:\/\/test.onephenix.com\/blog\/#website","url":"https:\/\/test.onephenix.com\/blog\/","name":"Phenix Health","description":"Online Doctor Australia | Telehealth Doctor | Phenix Health","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/test.onephenix.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-AU"},{"@type":"Person","@id":"https:\/\/test.onephenix.com\/blog\/#\/schema\/person\/200244242cc0ef8d220cb8b7c2aee868","name":"Gillian Alexis","image":{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/test.onephenix.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9ff8e52854b99dc898785ecf20f891c5e051e0f98d52a5228ff8d3ce2a7fe39b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9ff8e52854b99dc898785ecf20f891c5e051e0f98d52a5228ff8d3ce2a7fe39b?s=96&d=mm&r=g","caption":"Gillian Alexis"},"url":"https:\/\/test.onephenix.com\/blog\/author\/q7ewsfmf4x\/"}]}},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"Gillian Alexis","author_link":"https:\/\/test.onephenix.com\/blog\/author\/q7ewsfmf4x\/"},"_links":{"self":[{"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/wp\/v2\/posts\/880","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/wp\/v2\/comments?post=880"}],"version-history":[{"count":0,"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/wp\/v2\/posts\/880\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/wp\/v2\/media?parent=880"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/wp\/v2\/categories?post=880"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/wp\/v2\/tags?post=880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}